Basics Lifecore Biomedical, Inc. IPO Date: March 1, 1996 Sector: Healthcare Industry: Drug Manufacturers - Specialty and Generic Market Cap: $253.27M Activated in VL: True Average Daily Range Avg Daily Range: $0.18 | 2.94% Avg Daily Range (30 D): $0.16 | 2.21% Avg Daily Range (90 D): $0.16 | 2.20% Institutional Daily Volume Avg Daily Volume: .24M Avg Daily Volume (30 D): .15M Avg Daily Volume (90 D): .12M Trade Size Avg Trade Size (Sh.): 90 Avg Trade Size (Sh.) (30 D): 61 Avg Trade Size (Sh.) (90 D): 60 Institutional Trades Total Inst.Trades: 29 Avg Inst. Trade: $2.91M Avg Inst. Trade (30 D): $2.22M Avg Inst. Trade (90 D): $2.29M Avg Inst. Trade Volume: .4M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $5.02M Avg Closing Trade (30 D): $2.22M Avg Closing Trade (90 D): $2.75M Avg Closing Volume: 687.46K     News Oct 13, 2025 @ 11:00 AM Lifecore Biomedical to Participate at Upcoming Ind... Source: Lifecore Biomedical, Inc. Sep 27, 2025 @ 12:31 PM LIFECORE INVESTIGATION ALERT: Bragar Eagel & Squir... Source: Bragar Eagel & Squire, P.C. Aug 15, 2025 @ 12:42 AM LIFECORE ALERT: Bragar Eagel & Squire, P.C. is Inv... Source: Bragar Eagel & Squire, P.C. Jun 17, 2025 @ 11:00 AM Lifecore Biomedical Signs New 10-Year Commercial M... Source: N/A Jun 12, 2025 @ 11:00 AM Lifecore Biomedical Receives Accelerated Payment o... Source: N/A Financials   TTM Q4 2025 FY 2025 Basic EPS $-1.27 $-.03 $-1.27 Diluted EPS $-1.27 $-.03 $-1.27 Revenue $ 128.87M $ 36.44M $ 128.87M Gross Profit $ 40.3M $ 13.98M $ 40.3M Net Income / Loss $ -38.72M $ -1.15M $ -38.72M Operating Income / Loss $ -17.25M $ 5.33M $ -17.25M Cost of Revenue $ 88.57M $ 22.46M $ 88.57M Net Cash Flow $ -.2M $ 2.85M $ -.2M PE Ratio